Cargando…

Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma

PURPOSE: To retrospectively evaluate the short-term efficacy of omidenepag isopropyl (EYBELIS 0.002%) by assessing its intraocular pressure (IOP)-lowering capability and safety in patients with normal-tension glaucoma (NTG). PATIENTS AND METHODS: Fifty-four NTG patients (54 eyes) who were newly admi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Kenji, Inoue, Junji, Kunimatsu-Sanuki, Shiho, Nozaki, Norie, Shimizu, Kosuke, Ishida, Kyoko, Tomita, Goji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533234/ https://www.ncbi.nlm.nih.gov/pubmed/33061280 http://dx.doi.org/10.2147/OPTH.S271789

Ejemplares similares

Frequency of Use of Fixed-Combination Eye Drops by Patients with Glaucoma at Multiple Private Practices in Japan
por: Inoue, Kenji, et al.
Publicado: (2022)

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2013)

Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension
por: Matsuo, Masato, et al.
Publicado: (2022)

Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2011)

Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2012)

Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
por: Shiratori, Naka, et al.
Publicado: (2021)

Comparison of Optical Coherence Tomography Angiography and Laser Speckle Flowgraphy for the Diagnosis of Normal-Tension Glaucoma
por: Takeyama, Asuka, et al.
Publicado: (2018)

Factors Related to a Right-Left Difference in Visual Field Defect in the Eyes with Untreated Normal Tension Glaucoma
por: Moroi, Haruka, et al.
Publicado: (2018)

Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
por: Nakazawa, Toru, et al.
Publicado: (2022)

Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2018)

Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan
por: Miki, Atsuya, et al.
Publicado: (2022)

Association between Optic Nerve Head Microcirculation and Macular Ganglion Cell Complex Thickness in Eyes with Untreated Normal Tension Glaucoma and a Hemifield Defect
por: Anraku, Ayako, et al.
Publicado: (2017)

Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination
por: Inoue, Kenji, et al.
Publicado: (2020)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy
por: Inoue, Kenji, et al.
Publicado: (2017)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study
por: Nakakura, Shunsuke, et al.
Publicado: (2021)

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
por: Panarelli, Joseph F., et al.
Publicado: (2023)

Evaluation of Patterns and Correlations of the Degree of Conjunctival Hyperemia Induced by Omidenepag Isopropyl 0.002% and Ripasudil 0.4%
por: Terao, Etsuko, et al.
Publicado: (2020)

Cystoid macular edema associated with omidenepag isopropyl in a phakic eye with an implantable collamer lens: a case report
por: Bae, Byung-Jin, et al.
Publicado: (2023)

Efficacy of 27-Gauge Vitrectomy with Internal Limiting Membrane Peeling for Epiretinal Membrane in Glaucoma Patients
por: Yoshida, Masaaki, et al.
Publicado: (2019)

Normal-tension glaucoma (Low-tension glaucoma)
por: Anderson, Douglas R
Publicado: (2011)

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
por: Olander, Kenneth W., et al.
Publicado: (2021)

Factors Related to Superior and Inferior Hemifield Defects in Primary Open-Angle Glaucoma
por: Takeuchi, Remi, et al.
Publicado: (2019)

Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
por: Inoue, Kenji, et al.
Publicado: (2012)

Pulse Waveform Analysis of the Ocular Blood Flow Using Laser Speckle Flowgraphy before and after Glaucoma Treatment
por: Masai, Satoko, et al.
Publicado: (2019)

Update on Normal Tension Glaucoma
por: Mallick, Jyotiranjan, et al.
Publicado: (2016)

Comparison of OCT and HRT Findings Among Normal, Normal Tension Glaucoma, and High Tension Glaucoma
por: Shin, In Ha, et al.
Publicado: (2008)

Predicting the development of normal tension glaucoma and related risk factors in normal tension glaucoma suspects
por: Park, Hae-Young Lopilly, et al.
Publicado: (2021)

Time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002%: a pilot, comparative study versus ripasudil 0.4%
por: Terao, Etsuko, et al.
Publicado: (2020)

One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl
por: Oogi, Satomi, et al.
Publicado: (2020)

Selected autoantibodies and normal-tension glaucoma
por: Skonieczna, Katarzyna, et al.
Publicado: (2014)

Cognitive functions and normal tension glaucoma
por: Daveckaite, Akvile, et al.
Publicado: (2017)

Uncommon form of normal-tension glaucoma
por: Zemba, Mihail, et al.
Publicado: (2017)

Normal-tension glaucoma: Pathogenesis and genetics
por: Trivli, Alexandra, et al.
Publicado: (2019)

Importance of neuroimaging in normal tension glaucoma
por: Sharma, Jaideep, et al.
Publicado: (2020)

Normal-Tension Glaucoma: A Glymphopathy?
por: Wostyn, Peter, et al.
Publicado: (2023)

Pharmaceutical Approaches to Normal Tension Glaucoma
por: Salvetat, Maria Letizia, et al.
Publicado: (2023)

Size of the Optic Nerve Head and Its Relationship with the Thickness of the Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer in Patients with Primary Open Angle Glaucoma
por: Enomoto, Nobuko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mh90af1sj8m4joct2mld38j5h5